222110 temelleri
PANGEN BIOTECH INC. geli̇r dağilimina genel bakış
Gelir miktarına en büyük katkı Güney Korea tarafından yapılmıştır - geçen yıl PANGEN BIOTECH INC. 8.87 B KRW, ve ondan önceki yıl — 4.65 B KRW.
Kaynak tarafından
2017
2018
2019
2020
2021
2022
2023
2024
0,00
4,00 B
8,00 B
12,00 B
16,00 B
Contract Manufacturing Organization (CMO)
EPO Medicine
Royalty
Technology Transfer (CDO)
Other
Biopharmaceutical Products
Service
Technical Fee
Merchandise
Döviz: KRW
2017
2018
2019
2020
2021
2022
2023
2024
Contract Manufacturing Organization (CMO)
898,67 M
2,06 B
1,05 B
1,59 B
5,65 B
EPO Medicine
3,55 B
3,61 B
3,80 B
3,41 B
5,64 B
Royalty
449,52 M
752,46 M
689,58 M
270,59 M
1,15 B
Technology Transfer (CDO)
1,16 B
1,23 B
546,52 M
968,99 M
623,13 M
Other
131,44 M
290,43 M
420,01 M
1,07 B
1,61 B
Biopharmaceutical Products
—
—
—
—
—
Service
—
—
—
—
—
Technical Fee
—
—
—
—
—
Merchandise
—
—
—
—
—
Ülke bazında
2017
2018
2019
2020
2021
2022
2023
2024
0,00
4,00 B
8,00 B
12,00 B
16,00 B
South Korea
Overseas
Döviz: KRW
2017
2018
2019
2020
2021
2022
2023
2024
South Korea
3,57 B
2,91 B
2,84 B
4,65 B
8,87 B
Overseas
2,62 B
5,02 B
3,66 B
2,66 B
5,81 B